Funded Tech Companies

Evommune

Evommune, based in Palo Alto, raised money from Symbiosis, Beiersdorf and Avego Healthcare Capital.

Company Overview

Contact Information

Company Background Information

Overview

Evommune is different. We strive to develop accessible innovations that are meant to address symptoms as well as help avoid disease progression and medical complications in the future. Chronic inflammatory diseases are the most significant cause of death in the world, and those who live with them have a reduced quality of life. Many immunology-focused medications give patients a temporary fix to a longer-term problem--addressing symptom control rather than the root cause of disease.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

10/31/2024

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

Luis Peña

        

Chief Financial Officer

Kyle Carver

        

Chief Medical Officer

Eugene Bauer

        

Chief Scientific Officer

Jeegar Patel

        

Company Investors

• Symbiosis
• Beiersdorf
• Avego Healthcare Capital
• Pivotal bioVenture Partners
• B Capital Group
• RA Capital Management (Derek DiRocco)
• Longwood Fund
• Andera Partners
• FemHealth Ventures
• Sectoral Asset Management (François Beaubien)
• RTW Investments
• Amplitude Ventures
• EQT Life Sciences
• Marshall Wace
• Verition Fund Management
• Arix Bioscience

Browse more funded tech companies:

Evomail | Evonetix

Share this article

About Our Venture Capital Transactions Database

This venture capital transaction data comes via a partnership with VentureDeal.com, a leading provider of venture capital transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary